|
US10004684B2
(en)
|
2001-02-14 |
2018-06-26 |
Gw Pharma Limited |
Pharmaceutical formulations
|
|
GB2377633A
(en)
*
|
2001-05-11 |
2003-01-22 |
Gw Pharmaceuticals Ltd |
Pharmaceutical compositions comprising the cannabinoids THC and CBD
|
|
GB2381194A
(en)
*
|
2001-09-07 |
2003-04-30 |
Gw Pharmaceuticals Ltd |
Pharmaceutical formulations
|
|
WO2003063847A1
(en)
*
|
2002-02-01 |
2003-08-07 |
Gw Pharma Limited |
Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
|
|
GB0202385D0
(en)
*
|
2002-02-01 |
2002-03-20 |
Gw Pharma Ltd |
Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
|
|
IL148244A0
(en)
|
2002-02-19 |
2002-09-12 |
Yissum Res Dev Co |
Anti-nausea and anti-vomiting activity of cannabidiol compounds
|
|
DE10226494A1
(de)
*
|
2002-06-14 |
2004-01-08 |
Lts Lohmann Therapie-Systeme Ag |
Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
|
|
GB2391865B
(en)
*
|
2002-08-14 |
2005-06-01 |
Gw Pharma Ltd |
Improvements in the extraction of pharmaceutically active components from plant materials
|
|
US7344736B2
(en)
|
2002-08-14 |
2008-03-18 |
Gw Pharma Limited |
Extraction of pharmaceutically active components from plant materials
|
|
CA2994322A1
(en)
*
|
2002-08-14 |
2004-02-14 |
Gw Pharma Limited |
Botanical drug substances comprising various proportions of thc and cbd
|
|
ES2377819T3
(es)
|
2002-08-14 |
2012-04-02 |
Gw Pharma Limited |
Formulaciones líquidas cannabinoides para administración mucosal
|
|
GB2393182B
(en)
*
|
2002-09-23 |
2007-03-14 |
Gw Pharma Ltd |
Method of preparing cannabidiol from plant material
|
|
GB0222077D0
(en)
|
2002-09-23 |
2002-10-30 |
Gw Pharma Ltd |
Methods of preparing cannabinoids from plant material
|
|
GB2394894B
(en)
*
|
2002-11-04 |
2005-08-31 |
G W Pharma Ltd |
New use for pharmaceutical composition
|
|
EP1644349B1
(en)
|
2003-06-24 |
2014-04-09 |
GW Pharma Limited |
Pharmaceutical compositions comprising cabbinochreme type compounds
|
|
ES2235626B1
(es)
*
|
2003-11-10 |
2006-11-01 |
Almirall Prodesfarma, S.A. |
Formas de administracion masticables, no comprimidas dosificadas individualmente.
|
|
GB2414933B
(en)
*
|
2004-06-08 |
2009-07-15 |
Gw Pharma Ltd |
Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
|
|
GB2418612A
(en)
*
|
2004-10-01 |
2006-04-05 |
Gw Pharma Ltd |
Inhibition of tumour cell migration with cannabinoids
|
|
GB0425248D0
(en)
*
|
2004-11-16 |
2004-12-15 |
Gw Pharma Ltd |
New use for cannabinoid
|
|
CA2586358C
(en)
*
|
2004-11-16 |
2015-11-24 |
Gw Pharma Limited |
Use of tetrahydrocannabivarin (thcv) as neutral antagonist of the cb1 cannabinoid receptor
|
|
MX2007007038A
(es)
|
2004-12-09 |
2008-03-07 |
Insys Therapeutics Inc |
Formulacion de dronabinol en temperatura ambiente.
|
|
GB2431105A
(en)
|
2005-10-12 |
2007-04-18 |
Gw Pharma Ltd |
Cannabinoids for the treatment of pulmonary disorders
|
|
GB2432312A
(en)
*
|
2005-11-01 |
2007-05-23 |
Gw Pharma Ltd |
Pharmaceutical compositions for the treatment of pain
|
|
GB2434312B
(en)
*
|
2006-01-18 |
2011-06-29 |
Gw Pharma Ltd |
Cannabinoid-containing plant extracts as neuroprotective agents
|
|
GB2439393B
(en)
*
|
2006-06-23 |
2011-05-11 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
US9308175B2
(en)
*
|
2006-09-15 |
2016-04-12 |
Echo Pharmaceuticals B.V. |
Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
|
|
ATE516796T1
(de)
*
|
2006-09-15 |
2011-08-15 |
Echo Pharmaceuticals Bv |
Granulat mit einem pharmazeutischen wirkstoff und einem emulgator und herstellungsverfahren dafür
|
|
KR20090055606A
(ko)
|
2006-09-27 |
2009-06-02 |
니코노범 에이비 |
지향성 용도
|
|
GB2448535A
(en)
*
|
2007-04-19 |
2008-10-22 |
Gw Pharma Ltd |
New use for cannabinoid-containing plant extracts
|
|
GB2449691A
(en)
|
2007-05-31 |
2008-12-03 |
Gw Pharma Ltd |
A reference plant lacking medicinal active compound expression
|
|
US9035130B2
(en)
|
2007-05-31 |
2015-05-19 |
Gw Pharma Limited |
Reference plant, a method for its production, extracts obtained therefrom and their use
|
|
EP2421503A1
(en)
*
|
2009-04-23 |
2012-02-29 |
Londonpharma Ltd. |
Sublingual pharmaceutical composition comprising a neutral oil
|
|
BRPI1014139A2
(pt)
|
2009-06-29 |
2016-04-26 |
Bender Analytical Holding Bv |
sistema de liberação de fármacos compreendendo polioxazolina e um agente biotivo.
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
AT509000B1
(de)
*
|
2009-10-23 |
2012-12-15 |
Rausch Peter |
Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen
|
|
GB2479153B
(en)
*
|
2010-03-30 |
2014-03-19 |
Gw Pharma Ltd |
The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
US8529914B2
(en)
*
|
2010-06-28 |
2013-09-10 |
Richard C. Fuisz |
Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
GB2491118B
(en)
|
2011-05-20 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
GB201111261D0
(en)
|
2011-07-01 |
2011-08-17 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
|
|
GB2495118B
(en)
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB201117956D0
(en)
*
|
2011-10-18 |
2011-11-30 |
Otsuka Pharma Co Ltd |
Phytocannabinoids for use in the treatment of breast cancer
|
|
GB2496688B
(en)
|
2011-11-21 |
2016-06-29 |
Gw Pharma Ltd |
Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
|
|
WO2013164824A1
(en)
|
2012-05-03 |
2013-11-07 |
Magdent Ltd. |
Bone enhancement device and method
|
|
CN104363890B
(zh)
|
2012-05-07 |
2018-01-26 |
回音制药公司 |
含有大麻素的颗粒物及其制备方法和含有该颗粒物的口服给药单元
|
|
US9199960B2
(en)
|
2013-05-02 |
2015-12-01 |
Frederick R. Ferri |
Method and apparatus for processing herbaceous plant materials including the cannabis plant
|
|
US9333229B2
(en)
|
2013-10-16 |
2016-05-10 |
William Bjorncrantz |
Winterized crude cannabis extracts and methods of preparation and use
|
|
CN105873566B
(zh)
|
2013-10-29 |
2019-06-07 |
艾克制药有限公司 |
含有δ9-四氢大麻酚的压制片剂、其制造方法及此类片剂在口服治疗中的用途
|
|
CN105848646B
(zh)
|
2013-10-29 |
2019-10-22 |
艾克制药有限公司 |
包含大麻二酚的压制片剂、其制造方法以及此类片剂在口服治疗精神病症或焦虑症中的用途
|
|
US11033493B2
(en)
*
|
2013-12-02 |
2021-06-15 |
Intelgenx Corp. |
Film dosage form with extended release mucoadhesive particles
|
|
US9044390B1
(en)
|
2014-04-17 |
2015-06-02 |
Gary J. Speier |
Pharmaceutical composition and method of manufacturing
|
|
US9186386B2
(en)
|
2014-04-17 |
2015-11-17 |
Gary J. Speier |
Pharmaceutical composition and method of manufacturing
|
|
US11331279B2
(en)
|
2014-05-29 |
2022-05-17 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
US11911361B2
(en)
|
2014-05-29 |
2024-02-27 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
CA2950424C
(en)
|
2014-05-29 |
2023-03-14 |
Insys Pharma, Inc. |
Stable cannabinoid formulations
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
US11077086B2
(en)
|
2014-07-21 |
2021-08-03 |
Pharmaceutical Productions, Inc. |
Solid dosage form composition for buccal or sublingual administration of cannabinoids
|
|
US10117891B2
(en)
|
2014-09-16 |
2018-11-06 |
India Globalization Capital, Inc. |
Cannabinoid composition for treating pain
|
|
US9844518B2
(en)
|
2014-09-30 |
2017-12-19 |
MJAR Holdings, LLC |
Methods of growing cannabaceae plants using artificial lighting
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
JP2017535539A
(ja)
|
2014-10-21 |
2017-11-30 |
ユナイテッド カナビス コーポレイション |
大麻抽出物ならびにその調製方法および使用方法
|
|
EP3247359A4
(en)
|
2015-01-25 |
2018-08-08 |
India Globalization Capital, Inc. |
Composition and method for treating seizure disorders
|
|
WO2016126592A1
(en)
|
2015-02-02 |
2016-08-11 |
Axim Biotechnologies, Inc. |
Cannabinoid and sugar alcohol complex, methods to make and use
|
|
EP3277260B1
(en)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
|
US12303541B2
(en)
|
2015-04-01 |
2025-05-20 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
|
DK3302437T3
(da)
*
|
2015-05-28 |
2023-01-09 |
Radius Pharmaceuticals Inc |
Stabile cannabinoidformuleringer
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
WO2017027136A2
(en)
*
|
2015-07-08 |
2017-02-16 |
Flavocure Biotech, Llc |
Therapeutic agents containing cannabis flavonoid derivatives for the prevention and treatment of neurodegenerative disorders
|
|
US10456435B2
(en)
|
2015-07-15 |
2019-10-29 |
Christopher A. MCELVANY |
Topical antiviral formulations and methods of using the same
|
|
US10092855B2
(en)
|
2015-07-16 |
2018-10-09 |
Fritz Chess |
CO2 extraction and filtration system
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US10596159B2
(en)
|
2015-08-12 |
2020-03-24 |
India Globalization Capital, Inc. |
Method and composition for treating cachexia and eating disorders
|
|
WO2017066474A1
(en)
*
|
2015-10-15 |
2017-04-20 |
Preleve Therapeutics, Llc |
Compositions and methods for pain relief
|
|
IL244278A0
(en)
*
|
2016-02-24 |
2016-07-31 |
Cannabics Pharmaceuticals Inc |
Cannabinoid compositions, methods of manufacture and use thereof
|
|
ITUB20161247A1
(it)
*
|
2016-03-02 |
2017-09-02 |
Labomar S R L |
Compressa orodispersibile contenente un principio attivo liposolubile
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
EP3445838B1
(en)
|
2016-04-18 |
2023-05-10 |
Gene Pool Technologies, Inc. |
Isolation of plant extracts
|
|
JP6983868B2
(ja)
|
2016-04-22 |
2021-12-17 |
レセプター・ホールディングス・インコーポレイテッド |
即効性の植物由来医薬化合物及び栄養補給剤
|
|
US11529329B2
(en)
|
2016-05-27 |
2022-12-20 |
Nordiccan A/S |
Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
|
|
CA3026274A1
(en)
*
|
2016-06-02 |
2017-12-07 |
Acerus Pharmaceutical Corporation |
Nasal cannabidiol compositions
|
|
EP3471746A4
(en)
|
2016-06-15 |
2020-02-26 |
India Globalization Capital, Inc. |
METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS
|
|
US10765658B2
(en)
|
2016-06-22 |
2020-09-08 |
Mastix LLC |
Oral compositions delivering therapeutically effective amounts of cannabinoids
|
|
JP2019524655A
(ja)
|
2016-06-29 |
2019-09-05 |
キャンサイエンス イノベーションズ インコーポレーテッドＣａｎｎｓｃｉｅｎｃｅ Ｉｎｎｏｖａｔｉｏｎｓ Ｉｎｃ． |
脱炭酸大麻樹脂、その使用、及びそれを製造する方法
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
CA3031533A1
(en)
*
|
2016-07-25 |
2018-02-01 |
Ebbu Inc. |
New cannabis tablet formulations and compositions and methods of making the same
|
|
US9833408B1
(en)
*
|
2016-07-28 |
2017-12-05 |
Allen Greenspoon |
Orally administrable formulation
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
EA201892396A1
(ru)
|
2016-12-02 |
2019-04-30 |
Ресептор Лайф Сайенсиз, Инк. |
Быстродействующие растительные лекарственные соединения и биологически активные добавки
|
|
CN110149795B
(zh)
*
|
2016-12-02 |
2023-10-03 |
西姆莱斯股份公司 |
化妆品混合物
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
JP2020514282A
(ja)
*
|
2016-12-20 |
2020-05-21 |
ティルレイ，インコーポレイティド |
新規カンナビノイド組成物および使用方法
|
|
CA3050150C
(en)
*
|
2017-01-23 |
2021-07-06 |
CannTab Therapeutics Limited |
Immediate release cannabidiol formulations
|
|
WO2019036243A1
(en)
*
|
2017-08-16 |
2019-02-21 |
Molecular Infusions, Llc |
Formulations
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
CA3055060A1
(en)
|
2017-03-05 |
2018-09-13 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Compositions and methods for treating cancer
|
|
US10596485B2
(en)
|
2017-04-03 |
2020-03-24 |
Fritz Chess |
Multi-functional distiller
|
|
US10058531B1
(en)
|
2017-06-01 |
2018-08-28 |
Spartak LLC |
Dosage delivery film
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
US20200146984A1
(en)
*
|
2017-06-27 |
2020-05-14 |
Panaxia Pharmaceutical Industries Ltd. |
Combination of cannabinoids and at least one additional ingredient for the enhancement of therapeutic potency
|
|
US20200268657A1
(en)
*
|
2017-07-13 |
2020-08-27 |
Michael Gulyas |
Supplement tablet and packaging
|
|
CA3076929A1
(en)
*
|
2017-09-25 |
2019-03-28 |
Canopy Health Innovations |
Compositions comprising cannabidiol, tetrahydrocannabinol, terpenes, and flavonoids and use thereof in the treatment of insomnia
|
|
US10220061B1
(en)
|
2017-09-26 |
2019-03-05 |
Cynthia Denapoli |
Method of reducing stress and anxiety in equines
|
|
KR20200065009A
(ko)
*
|
2017-10-05 |
2020-06-08 |
리셉터 홀딩스, 인크. |
신속 개시 및 연장된 작용 식물계 및 합성 칸나비노이드 제형
|
|
GB2567240B
(en)
|
2017-10-09 |
2022-04-06 |
Senzer Ltd |
An inhaler particularly a cannabinoid inhaler and a method of assembling such an inhaler
|
|
US20200360291A1
(en)
*
|
2017-12-01 |
2020-11-19 |
Healthy Option Consulting Inc. |
Soft dual chambered liquid-gel capsule and method to deliver sublingual and ingestible cannabis compositions
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
LU101385B1
(en)
*
|
2018-01-12 |
2020-01-30 |
Nutrae Llc |
Encapsulated Cannabinoid Formulations For Oral Delivery
|
|
WO2019159185A1
(en)
|
2018-02-19 |
2019-08-22 |
To Pharmaceuticals Llc |
Compositions and methods for the treatment of protein energy wasting
|
|
US20210023053A1
(en)
|
2018-03-30 |
2021-01-28 |
India Globalization Capital, Inc. |
Method and composition for treating cns disorders
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
SI25373A
(sl)
*
|
2018-05-08 |
2018-08-31 |
Danijela Marković |
Naravna orodisperzibilna tableta
|
|
EP3790543A4
(en)
|
2018-05-11 |
2022-03-30 |
Rhodes Technologies Inc. |
COMPOSITIONS AND DOSAGE FORMS FOR ORAL ADMINISTRATION
|
|
GB201807801D0
(en)
|
2018-05-14 |
2018-06-27 |
Plantine Holdings Ltd |
Microparticles
|
|
CA3103504A1
(en)
*
|
2018-06-15 |
2019-12-19 |
CannPal Animal Therapeutics Limited |
Cannabinoid composition and methods of treatment using the same
|
|
BR112021001326A2
(pt)
*
|
2018-07-18 |
2021-04-20 |
Glatt Gmbh |
formulações de liberação prolongada de canabinoides
|
|
WO2020061703A1
(en)
*
|
2018-09-26 |
2020-04-02 |
Hexo Operations Inc. |
Cannabinoid-containing concentrate for making a product for human consumption having an improved taste profile and methods of manufacturing same
|
|
AU2019385420A1
(en)
|
2018-11-19 |
2021-07-08 |
Spoke Sciences, Inc. |
N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions
|
|
US20200170962A1
(en)
|
2018-11-30 |
2020-06-04 |
F. Markus Leweke |
Nasal cannabidiol compositions
|
|
WO2020107114A1
(en)
*
|
2018-11-30 |
2020-06-04 |
Canopy Growth Corporation |
Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use
|
|
DE102019100483A1
(de)
*
|
2019-01-10 |
2020-07-16 |
Lts Lohmann Therapie-Systeme Ag |
Oraler Dünnfilm
|
|
US11147805B2
(en)
|
2019-02-07 |
2021-10-19 |
Medipure Pharmaceuticals Inc. |
Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product
|
|
CA3040547C
(en)
*
|
2019-04-17 |
2021-12-07 |
Medcan Pharma A/S |
Cannabinoid lozenge formulation
|
|
PL3920891T3
(pl)
*
|
2019-04-17 |
2024-05-20 |
Nordiccan A/S |
Szybko rozpadające się tabletki kannabinoidowe
|
|
EP3969054A4
(en)
*
|
2019-05-16 |
2023-09-06 |
Aegis Therapeutics, LLC |
OIL-SOLUBLE MEDICINAL COMPOSITIONS AND METHODS OF USE THEREOF
|
|
DE102019211195A1
(de)
*
|
2019-07-26 |
2021-01-28 |
Add Advanced Drug Delivery Technologies Ltd. |
Verfahren und Vorrichtung zur Herstellung eines im Wesentlichen im wässrigen Milieu lösbaren Cannabinoid-Granulats
|
|
BR112022002479A2
(pt)
*
|
2019-08-12 |
2022-04-26 |
Tenshi Kaizen Private Ltd |
Composição farmacêutica e processo para preparar composição oral sólida de canabinóide em comprimidos liofilizados de desintegração rápida
|
|
JP7736671B2
(ja)
|
2019-08-30 |
2025-09-09 |
イーヴィー エスエー |
充填顆粒、これらの製造方法及びこれらの使用
|
|
CN110604195A
(zh)
*
|
2019-09-10 |
2019-12-24 |
普洱茶王茶业集团股份有限公司 |
一种普洱茶保健饮品及其制备方法
|
|
WO2021055777A1
(en)
*
|
2019-09-20 |
2021-03-25 |
Mycotechnology, Inc. |
Methods for reduction of bitterness in cannabinoids using mycelial materials
|
|
CN114650809A
(zh)
|
2019-10-03 |
2022-06-21 |
斯塔顿治疗公司 |
屈大麻酚的透皮递送
|
|
US12409131B2
(en)
|
2019-10-03 |
2025-09-09 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
JP7670700B2
(ja)
|
2019-10-11 |
2025-04-30 |
パイク セラピューティクス インコーポレイテッド |
発作性障害の治療用のカンナビジオール（ｃｂｄ）を含む経皮医薬組成物
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
US12121617B2
(en)
|
2019-10-14 |
2024-10-22 |
Pike Therapeutics Inc. |
Transdermal delivery of cannabidiol
|
|
WO2021074790A1
(en)
|
2019-10-14 |
2021-04-22 |
Pike Therapeutics, Inc., 1219014 B.C. Ltd. |
Transdermal delivery of cannabidiol
|
|
US12268699B2
(en)
|
2019-10-14 |
2025-04-08 |
Pike Therapeutics Inc. |
Transdermal delivery of tetrahydrocannabinol
|
|
EP3808341A1
(de)
*
|
2019-10-16 |
2021-04-21 |
ADD Advanced Drug Delivery Technologies, Ltd. |
Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen
|
|
US20220387376A1
(en)
*
|
2019-10-18 |
2022-12-08 |
Natural Extraction Systems, LLC |
Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents
|
|
JP2023504756A
(ja)
|
2019-12-09 |
2023-02-06 |
ニコベンチャーズ トレーディング リミテッド |
カンナビノイドを含む口腔用製品
|
|
WO2021116824A1
(en)
*
|
2019-12-09 |
2021-06-17 |
Nicoventures Trading Limited |
Oral product comprising a cannabinoid
|
|
WO2021116826A1
(en)
*
|
2019-12-09 |
2021-06-17 |
Nicoventures Trading Limited |
Oral product comprising a cannabinoid
|
|
JP7675078B2
(ja)
*
|
2019-12-09 |
2025-05-12 |
ニコベンチャーズ トレーディング リミテッド |
カンナビノイドを含む口腔用製品
|
|
WO2021151212A1
(en)
*
|
2020-01-31 |
2021-08-05 |
Hexo Operations Inc. |
System and method for quantifying, formulating and enhancing user experience profile of cannabis
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
WO2021245658A1
(en)
*
|
2020-06-01 |
2021-12-09 |
Technion Research And Development Foundation Limited |
Compositions and methods for treating headaches
|
|
GB2595692B
(en)
|
2020-06-03 |
2024-10-23 |
Senzer Ltd |
A refill for an inhaler particularly a cannabinoid inhaler
|
|
EP4188090A4
(en)
|
2020-07-28 |
2024-08-14 |
Impello Biosciences, Inc. |
METHODS AND COMPOSITIONS FOR MODIFYING SECONDARY METABOLITES IN PLANTS
|
|
WO2022026960A1
(en)
|
2020-07-31 |
2022-02-03 |
Natural Extraction Systems, LLC |
Compositions and methods related to excipients and cannabinoid formulations
|
|
CA3173493A1
(en)
*
|
2020-09-24 |
2022-03-31 |
Nicoventures Trading Limited |
Packaged formulation
|
|
AU2021347760B2
(en)
*
|
2020-09-24 |
2024-07-25 |
Nicoventures Trading Limited |
Formulation
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
WO2022085622A1
(ja)
|
2020-10-23 |
2022-04-28 |
富士カプセル株式会社 |
カンナビジオール含有シームレスソフトカプセル
|
|
WO2022103635A1
(en)
*
|
2020-11-16 |
2022-05-19 |
Orcosa Inc. |
Rapidly infusing platform and compositions for therapeutic treatment in humans
|
|
US11839602B2
(en)
|
2020-11-25 |
2023-12-12 |
Nicoventures Trading Limited |
Oral cannabinoid product with lipid component
|
|
WO2022200636A1
(en)
|
2021-03-26 |
2022-09-29 |
Insucaps Limited |
Pharmaceutical formulations, and methods for the production thereof
|
|
US12029720B2
(en)
|
2021-04-29 |
2024-07-09 |
Tilray Brands, Inc. |
Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
|
|
WO2023275864A1
(en)
*
|
2021-06-27 |
2023-01-05 |
Roxx Labs Ltd. |
A process for the preparation of aqueous cannabinoid compositions
|
|
EP4134073A1
(en)
|
2021-08-11 |
2023-02-15 |
HM HerbaMedica GmbH |
Pharmaceutical compositions comprising dendritic nanocarriers and cannabis active agents
|
|
AU2023214126A1
(en)
|
2022-01-28 |
2024-07-11 |
Vertanical GmbH |
Method for the production of a plant extract
|
|
CN119923256A
(zh)
*
|
2022-07-21 |
2025-05-02 |
长矛治疗股份有限公司 |
包含大麻素的连续递送系统及其医药用途
|
|
AU2024237033A1
(en)
*
|
2023-03-14 |
2025-09-04 |
Dsm Ip Assets B.V. |
Cannabinoid formulations
|